Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial
Saúde PúblicaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Contraception
- Publicado em
- 15 jan 2024
- Citações
- 2
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized controlled trial
Josep Perelló-Capó, Josep Estadella-Tarriel, Ignasi Gich-Saladich, Marta Bailón-Queiruga, Elisa Llurba-Olivé, Joaquim Calaf-Alsina
Descritores MeSH
- Intrauterine Devices, Medicated
- Intrauterine Devices, Copper
- Humans
- Personal Satisfaction
- Quality of Life
- Copper
- Levonorgestrel
- Female
Veja também
Estudos relacionados
- Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 study
- Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial
- Effectiveness, safety and overall satisfaction of early postpartum placement of hormonal IUD compared with standard procedure: An open-label, randomized, multicenter study
- Medical treatment of fibroids: FIGO best practice guidance